|
KIAA2026 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85630000038017E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3021000000446E-07 |
| Normal-vs-Stage2 |
7.397400E-04 |
| Normal-vs-Stage3 |
5.016800E-03 |
| Normal-vs-Stage4 |
6.3696000000002E-05 |
| Stage1-vs-Stage2 |
6.538200E-01 |
| Stage1-vs-Stage3 |
3.679200E-01 |
| Stage1-vs-Stage4 |
3.994000E-01 |
| Stage2-vs-Stage3 |
7.467800E-01 |
| Stage2-vs-Stage4 |
2.201400E-01 |
| Stage3-vs-Stage4 |
1.721590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.07679999548228E-08 |
| Normal-vs-AfricanAmerican |
6.11779999999396E-05 |
| Normal-vs-Asian |
9.376200E-04 |
| Caucasian-vs-AfricanAmerican |
5.205600E-01 |
| Caucasian-vs-Asian |
3.693600E-01 |
| AfricanAmerican-vs-Asian |
5.074000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.85679996009969E-09 |
| Normal-vs-Female |
1.806380E-02 |
| Male-vs-Female |
4.100600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.515800E-03 |
| Normal-vs-Extreme_Weight |
2.75289999684958E-08 |
| Normal-vs-Obese |
1.161910E-04 |
| Normal-vs-Extreme_Obese |
3.799000E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.439840E-01 |
| Normal_Weight-vs-Obese |
9.786600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.011200E-01 |
| Extreme_Weight-vs-Obese |
8.121700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.052800E-01 |
| Obese-vs-Extreme_Obese |
4.072600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.065830E-02 |
| Normal-vs-Age(41-60Yrs) |
2.798000E-04 |
| Normal-vs-Age(61-80Yrs) |
6.88339996113285E-09 |
| Normal-vs-Age(81-100Yrs) |
6.22519999993187E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.786400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.051600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.704300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.036140E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.644400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.623800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.14970000478721E-08 |
| Normal-VS-Type2 PRCC |
1.74360999999346E-05 |
| Normal-VS-KIRP CIMP |
4.196100E-02 |
| Normal-VS-Unclassified PRCC |
3.424400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.179400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.924350E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.002000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.361000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.635000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.868400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.32910000017317E-07 |
| Normal-vs-N1 |
5.842400E-04 |
| Normal-vs-N2 |
1.396070E-04 |
| N0-vs-N1 |
4.078000E-01 |
| N0-vs-N2 |
5.577800E-03 |
| N1-vs-N2 |
2.261000E-03 |
|
|
